Extracorporeal Shock Wave Therapy With a Wide Focus Probe for the Treatment of Erectile Dysfunction

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2012 by Rambam Health Care Campus.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
i_gruenwald, Rambam Health Care Campus
ClinicalTrials.gov Identifier:
First received: March 8, 2011
Last updated: December 18, 2012
Last verified: December 2012
Low intensity shockwaves (1/10 the ones used in Lithotripsy) are delivered to the penile tissue. Shockwaves are created by a special generator and are focused using a specially designed shockwave applicator apparatus. The shockwaves are delivered through the applicator covering the corpora cavernosa of the penis. In previous studies the investigators used a medium focused probe and in this study the investigators are evaluating results of this therapy using a wider focus probe in the aim of improving results of treatment.

Condition Intervention Phase
Erectile Dysfunction
Device: Low intensity shock waves
Phase 3

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Extracorporeal Shock Wave Therapy With a Wide Focus Probe for the Treatment of Erectile Dysfunction

Resource links provided by NLM:

Further study details as provided by Rambam Health Care Campus:

Primary Outcome Measures:
  • Change in IIEF-ED Domain Questionaire Score > 5 points is considered treatment success [ Time Frame: 13 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Rigidity Score Questionaire- an increase by at least 1 point is considered success [ Time Frame: 13 weeks ] [ Designated as safety issue: No ]

Estimated Enrollment: 70
Study Start Date: March 2011
Estimated Study Completion Date: December 2013
Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Treatment LI-ESWT
Device: Extracorporeal Shockwave Therapy Generator (Omnispec model ED1000) Gel is spread around the penis and on the Shock Wave applicator and Treatment (12 sessions in total) of 300 shocks per site, on 5 penile anatomical sites.
Device: Low intensity shock waves
1500 shocks, Energy Density - 0.09 mJ/mm2
Other Name: Omnispec model ED1000


Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • ED of more than 6 months
  • At least 50% unsuccessful to attempt sexual intercourse for 4 times at 4 different days
  • Positive response to PDE-5 inhibitors
  • IIEF-5 domain score of 12-20 denoting mild to severe ED
  • Non-Neurological pathology
  • Stable heterosexual relationship for more than 3 months

Exclusion Criteria:

  • NPT - normal/flat
  • Prior prostatectomy surgery
  • Any cause of ED other than vascular related
  • Any unstable medical, psychiatric, spinal cord injury, penile anatomical abnormalities
  • Clinically significant chronic hematological disease
  • Cardiovascular conditions that prevent sexual activity
  • History of heart attack, stroke or life-threatening arrhythmia within the prior 6 months.
  • Cancer within the past 5 years.
  • Anti-androgens, oral or injectable androgens
  • Use of any treatment for ED within 7 days of screening including oral medications, vacuum devices, constrictive devices, injections or urethral suppositories
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01317693

Contact: Ilan Gruenwald, MD 00972-4-8542882 i_gruenwald@rambam.health.gov.il

Rambam Medical Center Recruiting
Haifa, Israel
Contact: Ilan Gruenwald, MD    00972-4-8542882    i_gruewald@rambam.health.gov.il   
Principal Investigator: Yoram Vardi, Prof.         
Principal Investigator: Ilan Gruenwald, MD         
Sub-Investigator: Boaz Appel, MD         
Sub-Investigator: Yaron Ofer, MD         
Sub-Investigator: Suliman Nassar, MD         
Sub-Investigator: Omar Massarwa, RN BA         
Sub-Investigator: Ezra Gerber, RN BA         
Sponsors and Collaborators
Rambam Health Care Campus
Principal Investigator: Ilan Gruenwald, MD Rambam Health Care Campus
Study Director: Yoram Vardi, Prof. Rambam Health Care Campus
  More Information

Responsible Party: i_gruenwald, MD, Rambam Health Care Campus
ClinicalTrials.gov Identifier: NCT01317693     History of Changes
Other Study ID Numbers: 0571-10-RMB 
Study First Received: March 8, 2011
Last Updated: December 18, 2012
Health Authority: Israel: Ministry of Health

Keywords provided by Rambam Health Care Campus:
Erectile Dysfunction
Shock waves

Additional relevant MeSH terms:
Erectile Dysfunction
Genital Diseases, Male
Mental Disorders
Sexual Dysfunction, Physiological
Sexual Dysfunctions, Psychological

ClinicalTrials.gov processed this record on May 26, 2016